相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Phase 2a Trial Investigating the Safety and Tolerability of the Novel Cortical Enhancer IRL752 in Parkinson's Disease Dementia
Per Svenningsson et al.
MOVEMENT DISORDERS (2020)
(3S)-3-(2,3-difluorophenyl)-3-methoxypyrrolidine (IRL752)-a Novel Cortical-Preferring Catecholamine Transmission- and Cognition-Promoting Agent
S. Hjorth et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2020)
Use of integrated clinical trial protocols - A survey in early medicines development
Katharina Erb-Zohar et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2018)
Analysis of integrated clinical trial protocols in early phases of medicinal product development
Kevin Fruhner et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2017)
In Vivo Systems Response Profiling and Multivariate Classification of CNS Active Compounds: A Structured Tool for CNS Drug Discovery
Susanna Waters et al.
ACS CHEMICAL NEUROSCIENCE (2017)
Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease
Chandana Buddhala et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
Treatment of Psychosis and Dementia in Parkinson's Disease
Jennifer G. Goldman et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2014)
The Columbia-Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults
Kelly Posner et al.
AMERICAN JOURNAL OF PSYCHIATRY (2011)
A safety grading scale to support dose escalation and define stopping rules for healthy subject first-entry-into-man studies Some points to consider from the French Club Phase I working group
Michel Sibille et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
The Arc of synaptic memory
Clive R. Bramham et al.
EXPERIMENTAL BRAIN RESEARCH (2010)
Parkinson's disease: clinical features and diagnosis
J. Jankovic
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
Mariese A. Hely et al.
MOVEMENT DISORDERS (2008)
A brief measure for assessing generalized anxiety disorder -: The GAD-7
Robert L. Spitzer et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
The Parkinson's complex: Parkinsonism is just the tip of the iceberg
JW Langston
ANNALS OF NEUROLOGY (2006)
How first-time-in-human studies are being performed: A survey of phase I dose-escalation trials in healthy volunteers published between 1995 and 2004
C Buoen et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Memory-influencing intra-basolateral amygdala drug infusions modulate expression of Arc protein in the hippocampus
CK McIntyre et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Staging of brain pathology related to sporadic Parkinson's disease
H Braak et al.
NEUROBIOLOGY OF AGING (2003)
Optimizing first-time-in-human trial design for studying dose proportionality
Y Yin et al.
DRUG INFORMATION JOURNAL (2001)
The PHQ-9 - Validity of a brief depression severity measure
K Kroenke et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2001)
Postural instability in Parkinson's disease: a comparison with and without a concurrent task
M Morris et al.
GAIT & POSTURE (2000)
分享论文
